Transfusion Risks and Transfusion-related Pro-inflammatory Responses

Hematology/Oncology Clinics of North America

Volumn 21, Issue 1, 2007, Pages 147-161

  Despotis, George John ^a   Zhang, Lini ^a   Lublin, Douglas M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIHISTAMINIC AGENT; APROTININ; DIURETIC AGENT; HYPERTENSIVE FACTOR; PARACETAMOL; PSORALEN; TRANEXAMIC ACID;

ALLOIMMUNIZATION; APHERESIS; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BLEEDING; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; FEVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; NONHUMAN; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; PRURITUS; RASH; RESPIRATORY DISTRESS; RESUSCITATION; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY; ULTRAVIOLET B RADIATION; URTICARIA; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; HUMANS; INFLAMMATION; RISK FACTORS;

EID: 33846383781     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.11.002     Document Type: Review

References (74)

1. Goodnough L.T., Brecher M.E., Kanter M.H., et al. Transfusion medicine: blood transfusion. N Engl J Med 340 (1999) 438-447
2. Goodnough L.T., Shander A., and Brecher M.E. Transfusion medicine: looking to the future. Lancet 361 9352 (2003) 161-169
3. Whitaker B.I., and Sullivan M. 2005 nationwide blood collection and utilization survey report (2006), Department of Health and Human Services, Rockville (MD)
4. Toy P., Popovsky M.A., Abraham E., et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 33 (2005) 721-726
5. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005;19:2-31.
6. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 30 (1990) 583-590
7. McCullough J. Complications of transfusion. In: McCullough J. (Ed). Transfusion medicine (1999), McGraw-Hill, New York 337-359
8. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44 (2004) 1774-1789
9. Silliman C.C., Paterson A.J., Dickey W.O., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37 (1997) 719-726
10. Looney M.R., Gropper M.A., and Matthay M.A. Transfusion-related acute lung injury: a review. Chest 126 1 (2004) 249-258
11. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101 2 (2003) 454-462
12. Holness L., Knippen M.A., Simmons L., et al. Fatalities caused by TRALI. Transfus Med Rev 18 3 (2004) 184-188
13. Kopko P.M., Marshall C.S., MacKenzie M.R., et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 287 15 (2002) 1968-1971
14. Zallen G., Moore E.E., Ciesla D.J., et al. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock 13 1 (2000) 29-33
15. Stainsby D., Russell J., Cohen H., et al. Reducing adverse events in blood transfusion. Br J Haematol 131 (2005) 8-12
16. Stainsby D. Errors in transfusion medicine. Anesthesiol Clin North America 23 (2005) 253-261
17. Pineda A.A., Brzica Jr. S.M., and Taswell H.F. Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clin Proc 53 (1978) 378-390
18. Noninfectious complications of blood transfusion. In: Brecher M.E. (Ed). Technical manual (2002), American Association of Blood Banks, Bethesda (MA) 585-609
19. Linden J.V., Paul B., and Dressler K.P. A report of 104 transfusion errors in New York State. Transfusion 32 (1992) 601-606
20. Shulman I.A., Spence R.K., and Petz L.D. Surgical blood ordering, blood shortage situations, and emergency transfusions. In: Petz L.D., Swisher S.N., Kleinman S., et al. (Eds). Clinical practice of transfusion medicine (1996), Churchill Livingstone, New York 509-519
21. Firestone D.T. Adverse effects of blood transfusion. In: Rudman S.V. (Ed). Textbook of blood banking and transfusion medicine (1995), WB Saunders Co, Philadelphia 406-433
22. Landers D.F., Hill G.E., Wong K.C., et al. Blood transfusion-induced immunomodulation. Anesth Analg 82 (1996) 187-204
23. Blumberg N., and Heal J.M. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 101 (1996) 299-308
24. Edna T.H., and Bjerkeset T. Association between blood transfusion and infection in injured patients. J Trauma 33 5 (1992) 659-661
25. Agarwal N., Murphy J.G., Cayten C.G., et al. Blood transfusion increases the risk of infection after trauma. Arch Surg 128 2 (1993) 171-176
26. Claridge J.A., Sawyer R.G., Schulman A.M., et al. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68 (2002) 566-572
27. Hill G.E., Frawley W.H., Griffith K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54 (2003) 908-914
28. Murphy P., Heal J.M., and Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 31 (1991) 212-217
29. Esposito R.A., Culliford A.T., Colvin S.B., et al. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 85 2 (1983) 174-185
30. Jensen L.S., Andersen A.J., Christiansen P.M., et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 79 6 (1992) 513-516
31. Jensen L.S., Kissmeyer-Nielsen P., Wolff B., et al. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 348 9031 (1996) 841-845
32. Edna T.H., and Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer. Eur J Surg 164 6 (1998) 449-456
33. Tartter P.I. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 216 6 (1992) 633-638
34. Tartter P.I. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 75 8 (1988) 789-792
35. Vignali A., Braga M., Dionigi P., et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 161 7 (1995) 487-492
36. Houbiers J.G., van de Velde C.J., van de Watering L.M., et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 37 2 (1997) 126-134
37. Murphy P.J., Connery C., Hicks Jr. G.L., et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 104 4 (1992) 1092-1099
38. Chelemer S.B., Prato B.S., Cox Jr. P.M., et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 73 1 (2002) 138-142
39. Vamvakas E.C., and Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 39 (1999) 701-710
40. Tartter P.I., Mohandas K., Azar P., et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 176 5 (1998) 462-466
41. van de Watering L.M., Hermans J., Houbiers J.G., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97 (1998) 562-568
42. Bilgin Y.M., van de Watering L.M., Eijsman L., et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 109 (2004) 2755-2760
43. Baron J.F., Gourdin M., Bertrand M., et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg 94 3 (2002) 529-537
44. Titlestad I.L., Ebbesen L.S., Ainsworth A.P., et al. Leukocyte depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int J Colorectal Dis 16 3 (2001) 147-153
45. Wallis J.P., Chapman C.E., Orr K.E., et al. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 42 9 (2002) 1127-1134
46. Blumberg N., Heal J.M., Cowles J.W., et al. Leukocyte-reduced transfusions in cardiac surgery: results of an implementation trial. Am J Clin Pathol 118 (2002) 376-381
47. Sauaia A., Moore F.A., Moore E.E., et al. Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma 45 2 (1998) 291-301
48. Moore F.A., Moore E.E., and Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132 6 (1997) 620-624
49. Sauaia A., Moore F.A., Moore E.E., et al. Early predictors of postinjury multiple organ failure. Arch Surg 129 1 (1994) 39-45
50. Bucerius J., Gummert J.F., Borger M.A., et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75 2 (2003) 472-478
51. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 17 (2002) 1309-1317
52. Greendyke R.M. Cost analysis. Bedside blood glucose testing. Am J Clin Pathol 97 1 (1992) 106-107
53. Engoren M.C., Habib R.H., Zacharias A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74 4 (2002) 1180-1186
54. Lemmer Jr. J.H., Stanford W., Bonney S.L., et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 107 2 (1994) 543-553
55. Lemmer J.H., Dilling E.W., Morton J.R., et al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. Ann Thorac Surg 62 (1996) 1659-1667
56. Levy J.H., Pifarre R., Schaff H.V., et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92 (1995) 2236-2244
57. Alderman E.L., Levy J.H., Rich J.B., et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116 5 (1998) 716-730
58. Smith P.K. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg 62 (1996) 1575-1577
59. Levi M., Cromheecke M.E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354 9194 (1999) 1940-1947
60. Goodnough L.T. Autologous blood donation. Anesthesiol Clin North America 23 (2005) 263-270
61. Sonnenberg F.A., Gregory P., Yomtovian R., et al. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 39 (1999) 808-817
62. Goodnough L.T., Shander A., and Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 43 5 (2003) 668-676
63. Helm R.E., Rosengart T.K., Gomez M., et al. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 65 (1998) 125-136
64. Despotis G., Avidan M., and Lublin D.M. Off-label use of recombinant factor VIIA concentrates after cardiac surgery. Ann Thorac Surg 80 (2005) 3-5
65. Capraro L., Kuitunen A., Salmenpera M., et al. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Acta Anaesthesiol Scand 45 2 (2001) 200-206
66. Despotis G.J., Santoro S.A., Spitznagel E., et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 107 1 (1994) 271-279
67. Spiess B.D., Gillies B.S., Chandler W., et al. Changes in transfusion therapy and re-exploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9 (1995) 168-173
68. Shore-Lesserson L., Manspeizer H.E., DePerio M., et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88 (1999) 312-319
69. Nuttall G.A., Oliver W.C., Santrach P.J., et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94 5 (2001) 773-781
70. Royston D., and von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 86 (2001) 575-578
71. Avidan M.S., Alcock E.L., Da Fonseca J., et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgment in the management of bleeding after cardiac surgery. Br J Anaesth 92 2 (2004) 178-186
72. Chen L., Bracey A.W., Radovancevic R., et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 (2004) 425-431
73. Despotis G.J., Levine V., Saleem R., et al. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet 354 9173 (1999) 106-110
74. Mongan P.D., and Hosking M.P. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 77 1 (1992) 38-46